Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 120
- 主要终点
- visual analogue scale
研究概览
简要总结
evaluate the efficacy of hyaluronidase in different doses as an adjuvant to bupivacaine in ultrasound-guided TAB block during CS
详细描述
Hyaluronidase acts by catalyzing the hydrolysis of hyaluronan, decreased its viscosity, and enchasing the tissue permeability. So, this makes it a suitable additive for other drugs to speed up their distribution and delivery especially in ophthalmic surgery. Several studies showed that multiple injection techniques of TAB block were more successful with a faster onset of anesthesia and higher success rates, with a change in the incidence of complications.
This double-blinded randomized prospective study was conducted to evaluate the efficacy of hyaluronidase in different doses as an adjuvant to bupivacaine in ultrasound-guided TAB block during CS . The primary outcome of this study was the duration of sensory block, while secondary outcomes included the onset of sensory block, success rate, total doses of intraoperative rescue analgesia, number of patients needed for postoperative rescue analgesia, and complications.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 45 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •pregnant 20-45 y medical free
排除标准
- •• Hepatic.
- •Diabetic.
- •Hypertensive.
- •Cardiovascular dysfunction.
研究组 & 干预措施
group I
After skin closure, they got TAB block with 20 cc of 0.25 percent bupivacaine on each side without any adjuvant.
干预措施: Hyaluronidase (Drug)
group II
obtained After the skin was closed, we received TAB block with 20 ml of 0.25% bupivacaine and 5 ml of 0.9% normal saline containing 500 IU (100 IU/ml) of hyaluronidase (Hynidase) as an adjuvant on each side.
干预措施: Hyaluronidase (Drug)
GROUP III
obtained After the skin was closed, we received TAB block with 20 ml of 0.25% bupivacaine and 5 ml of 0.9% normal saline containing 1000 IU (200 IU/ml) hyaluronidase (Hynidase) as an adjuvant on each side.
干预措施: Hyaluronidase (Drug)
结局指标
主要结局
visual analogue scale
时间窗: 2-6-10-16-24 hours postoperatively
postoperatively pain assesment
次要结局
未报告次要终点
研究者
Mohamed said MOSTAFA elmeligy
anesthesia lecturer
Benha University
